283 related articles for article (PubMed ID: 26096891)
1. Current approaches to enhance glutamate transporter function and expression.
Fontana AC
J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
[TBL] [Abstract][Full Text] [Related]
2. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.
Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
Neuropharmacology; 2019 Dec; 161():107559. PubMed ID: 30851309
[TBL] [Abstract][Full Text] [Related]
3. GLT-1 transporter: an effective pharmacological target for various neurological disorders.
Soni N; Reddy BV; Kumar P
Pharmacol Biochem Behav; 2014 Dec; 127():70-81. PubMed ID: 25312503
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2.
Kortagere S; Mortensen OV; Xia J; Lester W; Fang Y; Srikanth Y; Salvino JM; Fontana ACK
ACS Chem Neurosci; 2018 Mar; 9(3):522-534. PubMed ID: 29140675
[TBL] [Abstract][Full Text] [Related]
5. The GLT-1 (EAAT2; slc1a2) glutamate transporter is essential for glutamate homeostasis in the neocortex of the mouse.
Bjørnsen LP; Hadera MG; Zhou Y; Danbolt NC; Sonnewald U
J Neurochem; 2014 Mar; 128(5):641-9. PubMed ID: 24224925
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.
Lee SG; Su ZZ; Emdad L; Gupta P; Sarkar D; Borjabad A; Volsky DJ; Fisher PB
J Biol Chem; 2008 May; 283(19):13116-23. PubMed ID: 18326497
[TBL] [Abstract][Full Text] [Related]
7. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model.
Falcucci RM; Wertz R; Green JL; Meucci O; Salvino J; Fontana ACK
ACS Chem Neurosci; 2019 Aug; 10(8):3437-3453. PubMed ID: 31257852
[TBL] [Abstract][Full Text] [Related]
8. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.
Kim K; Lee SG; Kegelman TP; Su ZZ; Das SK; Dash R; Dasgupta S; Barral PM; Hedvat M; Diaz P; Reed JC; Stebbins JL; Pellecchia M; Sarkar D; Fisher PB
J Cell Physiol; 2011 Oct; 226(10):2484-93. PubMed ID: 21792905
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
[TBL] [Abstract][Full Text] [Related]
10. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.
Green JL; Dos Santos WF; Fontana ACK
Biochem Pharmacol; 2021 Nov; 193():114786. PubMed ID: 34571003
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of transport stimulation of EAAT2 are located at interface between the trimerization and substrate transport domains.
Mortensen OV; Liberato JL; Coutinho-Netto J; Dos Santos WF; Fontana AC
J Neurochem; 2015 Apr; 133(2):199-210. PubMed ID: 25626691
[TBL] [Abstract][Full Text] [Related]
12. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.
Mitosek-Szewczyk K; Sulkowski G; Stelmasiak Z; Struzyńska L
Neuroscience; 2008 Jul; 155(1):45-52. PubMed ID: 18572325
[TBL] [Abstract][Full Text] [Related]
13. Parawixin1: a spider toxin opening new avenues for glutamate transporter pharmacology.
Torres-Salazar D; Fahlke C
Mol Pharmacol; 2007 Nov; 72(5):1100-2. PubMed ID: 17726155
[TBL] [Abstract][Full Text] [Related]
14. A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases.
Fontana IC; Souza DG; Souza DO; Gee A; Zimmer ER; Bongarzone S
J Med Chem; 2023 Feb; 66(4):2330-2346. PubMed ID: 36787643
[TBL] [Abstract][Full Text] [Related]
15. Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.
Colton CK; Kong Q; Lai L; Zhu MX; Seyb KI; Cuny GD; Xian J; Glicksman MA; Lin CL
J Biomol Screen; 2010 Jul; 15(6):653-62. PubMed ID: 20508255
[TBL] [Abstract][Full Text] [Related]
16. Histamine up-regulates astrocytic glutamate transporter 1 and protects neurons against ischemic injury.
Fang Q; Hu WW; Wang XF; Yang Y; Lou GD; Jin MM; Yan HJ; Zeng WZ; Shen Y; Zhang SH; Xu TL; Chen Z
Neuropharmacology; 2014 Feb; 77():156-66. PubMed ID: 23791559
[TBL] [Abstract][Full Text] [Related]
17. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.
Li Y; Sattler R; Yang EJ; Nunes A; Ayukawa Y; Akhtar S; Ji G; Zhang PW; Rothstein JD
Neuropharmacology; 2011 Jun; 60(7-8):1168-75. PubMed ID: 21034752
[TBL] [Abstract][Full Text] [Related]
18. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.
Wilson JM; Khabazian I; Pow DV; Craig UK; Shaw CA
Neuromolecular Med; 2003; 3(2):105-18. PubMed ID: 12728193
[TBL] [Abstract][Full Text] [Related]
19. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease.
Takahashi K; Kong Q; Lin Y; Stouffer N; Schulte DA; Lai L; Liu Q; Chang LC; Dominguez S; Xing X; Cuny GD; Hodgetts KJ; Glicksman MA; Lin CL
J Exp Med; 2015 Mar; 212(3):319-32. PubMed ID: 25711212
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
